Combined with the above results, we suggest that galectin-1/P38 MAPK/NF-κB/MDR1 axis at least in part contributes to developing the chemoresistance in CML. The gene discussed is LGALS1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.